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Postoperative Pentagastrin-Stimulated Serum Calcitonin
Concentrations in Patients with MeduDary Thyroid Carcinoma:
Reoperations in Patients with Concentrations Bordering the
Detection Liinit
Hinrich Meybier,* Heinrich Schmidt-Gayk,* Heinz Buhr,* and Friedhelm Raue*

The case reports on two patients with medullary thyroid carcinoma show that even postoperatively
stimulated serum calcitonin (CT) concentrations near the detection Umd (using a polyclonal antibody
against synthetic CT) can demonstrate persistent disease. Stimulated CT concentrations can be
lowered to nondetectable levels by a second and third operation ifa meticulous technique is used for
dissection of the lymph compartments. The patient can then be assumed lo be cured. Diagnostic
accuracy at very low CT concentrations can be improved by selective venous catheterization with
blood sampling for CT after stimulation. (Henry Ford Hosp MedJ 1989:37:138-40)

T

he most important parameters in diagnosis and follow-up of
patients with medullary thyroid carcinoma (MTC) are basal
calcitonin (CT) and stimulated CT (CTstim) concentrations
(1-7). Patients are assumed to be cured i f their postoperative
CTstim levets are in the normal range or even betow the timit of
detection (1,3,4,8,9). It seems possibte, however, that a smalt
tumor remnant does not have the potential to produce enough
CT, even after stimulation with pentagastrin and calcium, to be
an indicator for tumor persistence. The possibility of extrathyroidat CT production makes the interpretation of postoperafive CTstim even more difficult (10,11).
We report two patients whose postoperative CTstim levels
were found to be near the detection limit. During reoperations
metastatic tumor tissue could be removed. These patients are
cured in terms of our present follow-up invesfigations.

Case Reports
Case 1
A 24-year-old female member of a multiple endocrine neoplasia type
2A family had elevated CTstim levels repeatedly on routine screening.
Physical examination was unrevealing. Total thyroidectomy and bilateral selective neck dissection were perfonned. Histologic examination
of the specimens revealed multiple bilateral foci of MTC with C-cell
hyperplasia. Lymph node metastases were not found. Follow-up examinations of the patient were done twice a year. During thefirstfiveyears
postoperatively, CTstim levels were near the detection limit. At 60
months, elevated CTstim levels were found. At nine years the CTstim
concentrations were highly abnormal. Physical examination was unrevealing. Computed tomography and ultrasound investigations failed to
show residual tumor Selective venous catheterization with blood sampling revealed a CT concentration gradient in the area of the left proximal internal jugular vein. For this reason bilateral modified radical
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neck dissection according to the method by Tisell et al (12) was performed. Histologically, a metastatic lymph node measuring 8 mm in
diameter was discovered in the lateral compartment at the proximal portion of the left intemal jugular vein. After this operation the peripheral
venous CTstim concentrations were below limits of detection (Fig 1).
Selective venous blood sampling from the left intemal jugular vein after
pentagastrin stimulation gave identical results.

Case 2
This 44-year-old male patient had a cold nodule in the right thyroid
lobe which was treated by unilateral subtotal resection. A MTC with a
maximum diameter of 2.1 cm was found. In a second operation the remnant of the right lobe was removed, and contralateral subtotal resection
was performed. Since the CTstim levels remained pathologically elevated after this procedure, a third operation with excision of the remnant of the left lobe and bilateral modified neck dissection was performed. The histologic examination revealed lymph node metastases in
the right lateral compartment. After this third surgical intervention, peripheral CTstim was within the normal range. Selective venous blood
sampling showed a minute gradient for CT (0,07 versus 0,05 ng/mL) in
the proximal part of the right intemal jugular vein. In a fourth operation
a modified radical neck dissection according to the method by Tisell et
al (12) was done on the right side. Histologic examination revealed four
lymph node metastases (each measuring I mm in diameter) in the right
central compartment and one lymph node metastasis (2 mm in diameter) in the right lateral compartment. After this fourth operation the
CTstim levels proved to be below the limit of detection (Fig 2).
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Fig 1—Case 1; Pentagastrin-stimulated serum calcitonin (CT)
concentrations during follow-up after the first operation. The
closed circles represent CT values after pentagastrin and calcium gluconate stimulation, and the broken line represents the
detection limit of the assay.

Radioimmunoassay and stimulation of CT secretion
Radioimmunoassay used a polyclonal antibody against synthetic CT
with a normal range of < 0.1 to 0.3 ng/mL, intra- and interassay variation below 10% (13). For stimulation of CT secretion, pentagastrin
(Gastrodiagnost, Fa. Merck Darmstadt, West Germany) 0.5 |Jt.g/kg
body weight in 5 seconds intravenously (cases 1 and 2) and calcium
gluconate 2 mg/kg body weight in 1 minute intravenously (case 1) were
used (3,6).

Discussion
Postoperative CTstim is the cracial parameter for evaluating
the success of surgery in MTC patients. When pentagastrin- and
calcium gluconate-stimutated seram CT levels are repeatedly in
the tow nonnal range, then surgery is generally deemed curative
(1,3,4,8,9). The case reports presented show that the remaining
tumor volume may sometimes be so small that the amount of CT
released is insufficient for the diagnosis of persistent disease.
These results were obtained using a routine polyclonal antibody
for the CT radioimmunoassay. This problem of insensitivity
could be solved by performing a highly selective venous blood
sampling and measuring the higher concentration in a tumordraining vein. Experimental and clinical data have been reported
conceming the preoperative and postoperative status of patients
at risk for MTC (12,14-17). In case 1, we were able to demonstrate that the preoperatively observed CT concentration gradient disappeared after reoperation. Selective venous blood
sampling with stimulation of CT secretion reveated
postoperative concentrations betow the limit of detection. The
interpretation of postoperative CTstim is furthermore confused
because, after identical stimuli, different concentration gradients can be observed in short-term intervals (2).
Whether the outcome of postoperatve CTstim measurements
provides a basis for assuming that a patient has been perma-
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Fig 2—Case 2; Pentagastrin-stimulated serum calcitonin concentrations during follow-up after thefirst reoperation. The broken line represents the detection limit ofthe assay.

nentiy cured remains to be established. A tong-term follow-up is
required for confirmation.
A prerequisite for postoperative CTstim normalization is the
use of the method of Tisell et at (12) for centrat and lateral lymph
compartment dissection. This is particularty important for patients in whom tess aggressive procedures have failed (18-20).
The follow-up data on our patients suggest that even minimal
CTstim gradients show tumor persistence and that onty CTstim
levets betow detection limits provide much confidence for cure.
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